BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 19180265)

  • 1. Retroviral bicistronic vectors.
    Pfützner W
    Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
    Harries M; Phillipps N; Anderson R; Prentice G; Collins M
    J Gene Med; 2000; 2(4):243-9. PubMed ID: 10953915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
    Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
    J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved gene expression by a modified bicistronic retroviral vector.
    Hsieh CL; Chen BF; Wang CC; Liu HH; Chen DS; Hwang LH
    Biochem Biophys Res Commun; 1995 Sep; 214(3):910-7. PubMed ID: 7575563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using RT-prone recombination to promote re-building of complete retroviral vectors from two defective precursors: low efficiency and sequence specificities.
    Bru T; Galetto R; Piver E; Collin C; Negroni M; Pagès JC
    J Virol Methods; 2007 Jun; 142(1-2):118-26. PubMed ID: 17336399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
    Byun J; Kim JM; Robbins PD; Kim S
    Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES.
    Delluc-Clavières A; Le Bec C; Van den Berghe L; Conte C; Allo V; Danos O; Prats AC
    Gene Ther; 2008 Aug; 15(15):1090-8. PubMed ID: 18369321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
    Ghani K; Cottin S; Kamen A; Caruso M
    Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.
    Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A
    Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of retroviral vectors and helper cells for gene therapy.
    Hu WS; Pathak VK
    Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a new bicistronic retroviral vector with strong IRES activity.
    Martin P; Albagli O; Poggi MC; Boulukos KE; Pognonec P
    BMC Biotechnol; 2006 Jan; 6():4. PubMed ID: 16409632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
    Douin V; Bornes S; Creancier L; Rochaix P; Favre G; Prats AC; Couderc B
    BMC Biotechnol; 2004 Jul; 4():16. PubMed ID: 15279677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
    Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
    Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectable bicistronic vectors in skin gene therapy.
    Scheidemann F; Therrien JP; Pfützner W
    Arch Dermatol Res; 2008 Sep; 300(8):415-23. PubMed ID: 18663457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic transgenesis using retroviral vectors in the chicken embryo.
    Ishii Y; Reese DE; Mikawa T
    Dev Dyn; 2004 Mar; 229(3):630-42. PubMed ID: 14991718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral vector-mediated gene expression in hematopoietic cells.
    Baum C; Richters A; Ostertag W
    Curr Opin Mol Ther; 1999 Oct; 1(5):605-12. PubMed ID: 11249667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus vector-mediated gene transfer into the chick optic vesicle by in ovo electroporation.
    Sakuta H; Suzuki R; Noda M
    Dev Growth Differ; 2008 Aug; 50(6):453-7. PubMed ID: 18445068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression.
    Schambach A; Bohne J; Baum C; Hermann FG; Egerer L; von Laer D; Giroglou T
    Gene Ther; 2006 Apr; 13(7):641-5. PubMed ID: 16355114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgene expression and RNA interference in embryonic stem cells.
    Zaehres H; Daley GQ
    Methods Enzymol; 2006; 420():49-64. PubMed ID: 17161693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of transient expression system for retroviral vector production.
    Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
    J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.